Overview of clinical drug development from final preclinical selection, marketing approval, all phases of clinical trials, new strategies, challenges and solutions

About this Conference

Course Description:

Participants will be introduced to major clinical steps and considerations in the new drug development process. Starting with the selection of medically promising molecules, through the execution of major I-IV phases of clinical trials, and ending in clinical profiling for marketing.

The course will address:

Standard procedures;
New strategies implemented in clinical trials;
Selection of clinical investigators, consultants and opinion leaders;
Interactions with regulatory agencies in various countries;
Impact of regulations on the programs; as well as other common challenges.
Participants will learn about similarities and differences in clinical strategies for standard vs unique molecules, for domestic vs global programs, and for large pharma projects vs small biotech companies.

Who will Benefit:

Junior or new staff of clinical pharmacology and clinical research departments.
Pre-clinical, business, legal and marketing professionals who wish to become familiar with the clinical drug development process and the interpretation of clinical data.
Investment or licensing community members who are interested in clinical programs, particularly in the process of planning, costs, timing and issues of clinical evolutions and/or profiling of new molecule.
Clinical research associates, project managers, research scientists, medical writers, clinical statisticians, junior regulatory personnel, licensing and acquisition staff.
Any college graduates who are contemplating careers in clinical research involving the bio-pharma industry.

For Registration - http://www.complianceonline.com/clinical-drug-development-process-seminar-training-80325SEM-prdsm?channel=confroll

Note: Use coupon code NB5SQH8N and get 10% off on registration.